Tesaro, Inc. TSRO NASDAQ

NASDAQ • Healthcare • Biotechnology • USD

SharesGrow Score

32/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Tesaro, Inc. (TSRO) reported total assets of $862.19M and total liabilities of $613.1M for fiscal year 2017, resulting in total equity of $249.09M.

The company held $643.1M in cash and short-term investments. Total debt stood at $437.11M, with net debt of $-205.99M. The Debt-to-Equity (D/E) ratio was 1.75 (leveraged).

Current ratio is 4.74, indicating strong short-term liquidity. Interest coverage is -24.3x (weak).

Criteria supported by this page:

HEALTH (33/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (58/100) — Total assets $862.19M and equity $249.09M support the company's competitive scale

Overall SharesGrow Score: 30/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

32/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

33/100

Debt-to-Equity & liquidity

Proven by this page

MOAT

58/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Tesaro, Inc. Balance Sheet History

Metric	FY2017	FY2016	FY2015	FY2014
Total Assets	$862.19M	$839.85M	$255.28M	$263.9M
Total Liabilities	$613.1M	$228.63M	$168.41M	$139.85M
Total Debt	$437.11M	$131.78M	$121.33M	$115.48M
Cash & Investments	$643.1M	$785.88M	$230.15M	$256.86M
Total Stockholders Equity	$249.09M	$611.21M	$86.87M	$124.06M